Prevalence of Hepatitis B and C in Oral & Maxillofacial Surgery reported at Liaquat University Hospital Hyderabad

1. Muhammad Shehzad 2. Zaib un Nisa 3. Qadeer ul Hassan 4. Ghulam Habib

1. Asstt. Prof. of Oral & Maxillofacial Surgery  2. Asstt. Prof. of Oral Medicine and Periodontology,
3. Asstt. Prof. of Oral & Maxillofacial Surgery 4. Lecturer of Oral & Maxillofacial Surgery,
Liaquat University of Medical & Health Sciences Jamshoro


Objective: To analyze the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) carriers in oral and maxillofacial patients.

Study Design: Experimental study.

Place and Duration of Study: This study was carried out at Oral & Maxillofacial Surgery Department, Liaquat University Hospital Hyderabad from 1st September 2011 to 31st August 2013.

Materials and Methods: Data of 520 patients who were hospitalized at Liaquat University Hospital for treatment of maxillofacial fractures. Study design was descriptive/cross sectional study. All patients were treated both under general anesthesia as well as local anesthesia, sedation. Our hospital is tertiary referral center for Sindh province. Patients who were hospitalized at Oral & Maxillofacial Surgery Department during the study period for any category of maxillofacial surgery were screened before managing.

Results: 60% were males and 40% were females with age from 15-80 years. HBV was positive 15% in patients and HCV was positive in 11% of patients.

Conclusion: The high prevalence of HBV and HCV in maxillofacial surgical patients recommended a regular test for HBV and anti-HCV for every one patient, to prevent spread of HBV and HCV among staff, patient to patient and oral surgeon.

Key Word: Maxillofacial, HBV, HCV


Viral hepatitis is a severe worldwide community healthiness trouble. At current, six diverse types of hepatitis virus have been recognized and called as hepatitis A, B, C, D and E1. It is predictable that three to four million persons are infected each year. Pakistan is the intermediate HBV prevalence zone with carrier rate of 3-4% where both HBV and HCV are emerging as a major health problem2, more than 2000 million populations global and 350 million people are carrier of the virus by the presence of HBSAG surface antigen2. 130 million are chronic HCV carriers and are at risk of heaptocellular carcinoma3. Examination of maxillofacial surgical patients for hepatitis B and C undergo maxillofacial surgery is regular set of rules at maxillofacial department civil hospital Hyderabad. Universal precautions against HBV and HCV are not in use only when a known positive case operated. Patient under departing in Oral & Maxillofacial Surgery, must use standard practice of cross infection control to stop extend of infectivity to community. 

This study was carried out to see the occurrence of HBV and HCV in oral and maxillofacial surgical patients before operating on them.



We carried out this study Descriptive / cross-sectional Oral and maxillofacial surgery department of this university deals in all Indoor admitted of maxillofacial surgical patients. Over a period of two year starting from 1st Sept, 2009 to 31st Aug 2011. A total of 520 patients were admitted and treated both under general anesthesia as well as local anesthesia, sedation. All patients screened for HBsAg and anti- HCV to notice the carrier standing of the patients earlier than surgery. Every single one having the HBV and HCV positive patients were referred to general medicine department to consult physician liver function tests (L F T) SGOT SGPT, ALT and BT. CT  PT, APTT before treatment subject to fitness general anesthesia and under local anesthesia for any type of minor or major surgical procedure. All relative information was collected through annual admission register and patient treatment files and noted on predesigned proforma. Data was analyzed through SPSS-17.


A total number of 520 patients were screened for HBsAg and anti-HCV. 315(60%) were males and 205(40%) were females. The age was from 15 to 80 years.  139(26%) were positive for  HBsAg  and HCV. HBsAg were positive in 79(15%) patients. Out of them 49(62%) were males and 30(35%) were females. HCV was positive in 60(11%) patients, 40(66%) males and 20(33%) females. Total cases 56(40%) patients had prior history of surgical procedures as indoor or outdoor case. Only 23(4%) patients knew about their hepatitis status, while a bulk of patients 106(76%) were not known of their hepatitis position before they admitted  to civil hospital Hyderabad oral maxillofacial department  and they were diagnosed on screening by ELISA method. All the recently diagnosed cases of hepatitis B and C were also referred to Medicine Department of Liaquat University Hospital for further Evaluation.

Table No.1:Prevalence of Hepatitis B virus n=520 patient

Hepatitis B  Virus

No of Patient















Table No.2: Prevalence of Hepatitis C Virus n=520 patients

Hepatitis C  Virus

No of Patient

















Viral hepatitis has been diagnosed by coincidence in hospital based admitted impatient individuals who has no history   and symptom of hepatitis3,4.

Hepatitis B (HBV) and C (HCV) viral infection are spread all the way during blood and body secretions which break during the human body from side to side a contravene in the skin, mucosa or vein. The most common routes of conduction of HCV in urbanized country take account of intravenous drug use, blood transfusions, haemodialysis, needle-stick injuries, tattooing, sexual intercourse and peri-natal infections5,6.13.

In mounting countries, beneficial injections from reuse needles and syringe and indecent sterilization of all-encompassing medical procedure is the major means of transportation for spread of blood borne organisms together with hepatitis B virus HBV, HCV and HIV.  And  Overuse and unsafe injection7,8.14.

Hospital based  Maxillofacial surgery are at high jeopardy of getting the hepatitis B and C virus, since they have extended surgical  operation uncovered to the virus whereas, from perforation of glove, wire stick injury, accidental pricks. Low quality glove and extend used of glove more than one hour in surgical field 9.15.16. The occurrence of hepatitis in exacting is established to be elevated in public sector hospital due to over load patient admission10. A study carried out by Mujeeb et al10.17.18 showed the frequency of HBsAg 7% in doctors, 17% among dentists and 20% in sweepers working in the hospitals. On the other last part ,  there is accepting of hepatitis B and C infection and carelessness while dealing operating and proper dispose off material among the health care profession.

In this study the frequency of HBV infection was to be 11% compared to 6.5% diagnosed in a tertiary care hospital of Karachi in the surgical patients5.19.20. A study carried out in the surgical out patients department in 2006 Fauji Foundation Hospital Rawalpindi established 2.28% prevalence of hepatitis B and 7.56%11. At  the other hand , has been a prove that known patient  at high risk spreading for hepatitis B and C among clinical staff and society while dealing and operating patient11,12.21.22. What measures should to be taken to stop spread infection .like proper handling of instrument and glove should be used to deal any patient. And clinical staff must be trained dispose off material. Yet, the question of whether and how contaminated individuals should be arrangement out .to prevent spread of Infection and diagnosed and refer to proper treatment protocol.


The high prevalence of hepatitis B and C found in maxillofacial surgical patient recommend each and every patient assume having hepatitis and should take routine screening of HBsAg and anti-HCV .prior to any surgical procedure. This will allow to implement of universal precautions to transmission of infection HBSAg. HCV both, patient to clinical staff & patient to surgeon as well as to public and society.


1.       Khokhar N, Gill ML, Malik GJ. General seroprevalence of hepatitis C and hepatitis B virus infections in population, J Coll Physicians Surg Pak 2004; 14: 534-6.            

2.       Tariq WZ, Akram S, Qureshi TZ. Frequency of hepatitis B and C in central Punjab. Pak J Pathol 2006; 17: 140-1.                                                                                                 

3.       Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S,et al, Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ 2000; 78: 956-63.

4.       Ijaz AU, Shafiq F, Toosi NA. Hepatitis B and hepatitis C in blood donors: analysis of 2-years data. Ann King Edward Med Coll 2007; 13: 59-61

5.       Aziz S, Memon A, Tily HI, Rasheed K, Jehangir K, Quraishy MS. Prevalence of HIV, hepatitis B and C \amongst health workers of Civil Hospital Karachi. J Pak Med Assoc 2002; 52: 92-4.

6.       Mujeeb SA. Prevalence of HBs Ag and HCV antibodies in hepatocellular carcinoma in Karachi. Trop Doctor 1996; 27: 297.

7.       Winsome CJ, Lee RJ. Increased seroprevalence of hepatitis B in dental personnel necessitates awareness of revised pediatric hepatitis B vaccine recommendations. J Public Health Dent 1993;

8.       Chaudhary IA, Khan SA, Saminullah should we do hepatitis C screening on each patient before surgery; Analysis of 142 cases. Pak J Med Sci 2005;21:278-80.

9.       Thomas DL, Gruninger SX, Siew C, Joy ED, Quinum TC. occupational risk of hepatitis C infections among general dentist and oral surgeons in North America. Am Med 1996;1:564-9S

10.    Mujeeb SA, Zubari SJ, Lodhi TZ, Mehmood K. prevalence of HBV infection in health care personals. J Pak Med Assoc 1994;44:265.

11.    Takata Y. Tominaga K, et al. prevalence of hepatitis viral infection in dental patient with impacted teeth or jaw deformatie. Oral Surg Oral Med Oral Patho Oral Radio Endod 2003;96:31.

12.    Chaudhary IA. Khan SS, Majrooh MA, Alvi AA. Seroprvalence of hepatitis B and C among the patient reporting in surgical OPD at Fouji Foundation Hospital Rawalpindi. Review of 5 year literature.P512

13.    Stein K, Dalziel K, Walker A, Jenkins B, Round A, Royle P. Screening for Hepatitis C in injecting drug users: a cost utility analysis. J Public Health (Oxf) 2004, 26:61-71.

14.    Stein K, Dalziel K, Walker A, Jenkins B, Round A, Royle P. Screening for hepatitis C in genito-urinary medicine clinics: a cost utility analysis. J Hepatol 2003.

15.    Stein K, Dalziel K, Walker A, McIntyre L, Jenkins B, Horne J, et al. Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice. Health Technol Assess, 2002.

16.    Eckman MH, Kaiser TE, Sherman KE. The cost-effectiveness of screening for chronic hepatitis B infection in the United States.Clin Infect Dis 2011.

17.    Loubiere S, Rotily M, Moatti JP. Prevention could be less cost-effective than cure: the case of hepatitis C screening policies in France Int J Technol Assess Health Care 2003;19:632-645.

18.    Singer ME, Younossi ZM. Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults. Am J Med 2001;111:614-621.

19.    Tormans G, Van Damme P, Carrin G, Clara R, Eylenbosch W. Cost-effectiveness analysis of prenatal screening and vaccination of hepatitis B virus - the case of Belgium. Soc Sci Med 1993, 37:173-181.

20.    Jordan R, Law M. An appraisal of the efficacy and cost-effectiveness of antenatal screening for hepatitis B. J Med Screen 1997;4:117-127.

21.    Dwyer MJ, McIntyre PG. Ante-natal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area. Epidemiol Infect 1996; 117:121-131.

22.    Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol 2003;18:551-55.





Address for Corresponding Author:

Dr. Muhammad Shahzad

Assistant Professor of Oral Maxillofacial Surgery

Liaquat University of Medical & Health Sciences,

EMAIL: This email address is being protected from spambots. You need JavaScript enabled to view it.


Mobile No. 0333-2641067